home / stock / adtx / adtx quote
Last: | $2.39 |
---|---|
Change Percent: | 2.77% |
Open: | $2.46 |
Close: | $2.39 |
High: | $2.65 |
Low: | $2.3801 |
Volume: | 65,573 |
Last Trade Date Time: | 04/26/2024 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$2.39 | $2.46 | $2.39 | $2.65 | $2.3801 | 65,573 | 04-26-2024 |
$2.53 | $2.31 | $2.53 | $2.69 | $2.2679 | 181,004 | 04-25-2024 |
$2.37 | $2.41 | $2.37 | $2.41 | $2.27 | 28,039 | 04-24-2024 |
$2.27 | $2.33 | $2.27 | $2.33 | $2.18 | 26,138 | 04-23-2024 |
$2.22 | $2.4 | $2.22 | $2.4 | $2.14 | 62,239 | 04-22-2024 |
$2.35 | $2.48 | $2.35 | $2.48 | $2.29 | 14,932 | 04-19-2024 |
$2.41 | $2.55 | $2.41 | $2.55 | $2.28 | 55,414 | 04-18-2024 |
$2.35 | $2.4 | $2.35 | $2.46 | $2.33 | 38,392 | 04-17-2024 |
$2.43 | $2.59 | $2.43 | $2.59 | $2.306 | 42,480 | 04-16-2024 |
$2.67 | $3 | $2.67 | $3.08 | $2.6 | 85,660 | 04-15-2024 |
$3.01 | $3.16 | $3.01 | $3.21 | $3 | 83,184 | 04-12-2024 |
$3.15 | $3.19 | $3.15 | $3.26 | $3.11 | 41,310 | 04-11-2024 |
$3.12 | $3.23 | $3.12 | $3.23 | $3.06 | 90,637 | 04-10-2024 |
$3.3 | $3.06 | $3.3 | $3.4178 | $3.06 | 229,487 | 04-09-2024 |
$3.11 | $3.12 | $3.11 | $3.15 | $3 | 158,565 | 04-08-2024 |
$3.11 | $3.34 | $3.11 | $3.42 | $3.06 | 227,479 | 04-05-2024 |
$3.24 | $3.06 | $3.24 | $3.5 | $2.99 | 443,212 | 04-04-2024 |
$3.09 | $3.16 | $3.09 | $3.2 | $3.01 | 887,518 | 04-03-2024 |
$3.37 | $5.128 | $3.37 | $5.45 | $3.3 | 16,001,372 | 04-02-2024 |
$3.18 | $3.38 | $3.18 | $3.64 | $3.18 | 261,004 | 04-01-2024 |
News, Short Squeeze, Breakout and More Instantly...
ADiTx Therapeutics Inc. Company Name:
ADTX Stock Symbol:
NASDAQ Market:
Shares of Stryve Foods, Inc. (NASDAQ: SNAX) fell sharply during Tuesday’s session following a fourth-quarter revenue miss. Stryve Foods post...
Aditxt, Inc. (NASDAQ:ADTX) shares are volatile Tuesday after the company announced it will acquire Appili Therapeutics. The Details: Aditxt’s...
Transaction consideration provides a significant premium to the Appili shareholders Combined enterprise expected to provide enhanced synergies and...